These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 30626391)

  • 1. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy.
    Huang R; Chen Q; Zhang L; Luo K; Chen L; Zhao S; Feng L; Zhang J
    Environ Health; 2019 Jan; 18(1):5. PubMed ID: 30626391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with hypertensive disorders of pregnancy in the Atlanta African American Maternal-Child cohort.
    Thompson M; Eatman JA; Dunlop AL; Barr DB; Kannan K; Corwin EJ; Ryan PB; Panuwet P; Yakimavets V; Taibl KR; Tan Y; Liang D; Eick SM
    Chemosphere; 2024 Jun; 357():142052. PubMed ID: 38631500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort.
    Preston EV; Hivert MF; Fleisch AF; Calafat AM; Sagiv SK; Perng W; Rifas-Shiman SL; Chavarro JE; Oken E; Zota AR; James-Todd T
    Environ Int; 2022 Jul; 165():107335. PubMed ID: 35696844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considering environmental exposures to per- and polyfluoroalkyl substances (PFAS) as risk factors for hypertensive disorders of pregnancy.
    Erinc A; Davis MB; Padmanabhan V; Langen E; Goodrich JM
    Environ Res; 2021 Jun; 197():111113. PubMed ID: 33823190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to perfluoroalkyl substances in early pregnancy and the risk of hypertensive disorders of pregnancy: A nested case-control study in Guangxi, China.
    Liu B; Wei B; Mo M; Song Y; Tang C; Tang P; Guo X; Tan C; Liu S; Huang D; Qiu X
    Chemosphere; 2022 Feb; 288(Pt 1):132468. PubMed ID: 34624345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study.
    Borghese MM; Walker M; Helewa ME; Fraser WD; Arbuckle TE
    Environ Int; 2020 Aug; 141():105789. PubMed ID: 32408216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Richardson DB; Baird DD; Haug LS; Stuebe AM; Klungsøyr K; Harmon Q; Becher G; Thomsen C; Sabaredzovic A; Eggesbø M; Hoppin JA; Travlos GS; Wilson RE; Trogstad LI; Magnus P; Longnecker MP
    Am J Epidemiol; 2014 Apr; 179(7):824-33. PubMed ID: 24557813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study.
    Chen Q; Huang R; Hua L; Guo Y; Huang L; Zhao Y; Wang X; Zhang J
    Environ Health; 2018 Jan; 17(1):8. PubMed ID: 29343261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
    Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluoroalkyl and polyfluoroalkyl substances and hypertensive disorders of pregnancy: A systematic review and meta-analysis.
    Hu CY; Qiao JC; Gui SY; Xu KX; Dzhambov AM; Zhang XJ
    Environ Res; 2023 Aug; 231(Pt 2):116064. PubMed ID: 37178750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study.
    Yu G; Jin M; Huang Y; Aimuzi R; Zheng T; Nian M; Tian Y; Wang W; Luo Z; Shen L; Wang X; Du Q; Xu W; Zhang J;
    Environ Int; 2021 Nov; 156():106621. PubMed ID: 33984575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of perfluoroalkyl substances from mother to fetus in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Basterrechea M; Grimalt JO; Jiménez AM; Kraus T; Schettgen T; Sunyer J; Vrijheid M
    Environ Res; 2015 Oct; 142():471-8. PubMed ID: 26257032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
    Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
    Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women.
    Wikström S; Lindh CH; Shu H; Bornehag CG
    Sci Rep; 2019 Jun; 9(1):9179. PubMed ID: 31235847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to perfluoroalkyl substances and thyroid hormone concentrations in cord plasma in a Chinese birth cohort.
    Liang H; Wang Z; Miao M; Tian Y; Zhou Y; Wen S; Chen Y; Sun X; Yuan W
    Environ Health; 2020 Nov; 19(1):127. PubMed ID: 33243245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
    Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
    Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of per- and polyfluoroalkyl substances with maternal early second trimester sex-steroid hormones.
    Pacyga DC; Papandonatos GD; Rosas L; Whalen J; Smith S; Park JS; Gardiner JC; Braun JM; Schantz SL; Strakovsky RS
    Int J Hyg Environ Health; 2024 Jun; 259():114380. PubMed ID: 38657330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between prenatal perfluorinated compounds exposure and risk of pregnancy complications: A meta-analysis.
    Pang L; Li M; Dukureh A; Li Y; Ma J; Tang Q; Wu W
    Ecotoxicol Environ Saf; 2024 Mar; 272():116017. PubMed ID: 38290316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.